Skip to main content
Seunggyun Ha on Muck Rack

Seunggyun Ha

As seen in: Nature, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Seunggyun

Contact Seunggyun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cardiac sympathetic degeneration informs the duration of the prodromal stage of body-first Lewy body disease

|
By Casper Skjærbæk, Ole Munk, Katrine B. Andersen, Anushree Krishnamurthy, Karoline Knudsen, Sang-Won Yoo, Dong-Woo Ryu, Seunggyun Ha, Joong-Seok Kim, Per Borghammer, Jacob Horsager, Thea Lillethorup, Yoonsang Oh
| Nature Verified
Abstract Body-first Lewy body disease (LBD) is hypothesized to begin in the peripheral autonomic nervous system years before nigrostriatal involvement. Isolated REM sleep behaviour disorder (iRBD) is considered an early manifestation of body-first LBD but is preceded by an unknown period of peripheral autonomic degeneration. Consequently, the total duration of the prodromal phase remains unknown.
Open in Who Shared Issue with article?

Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer

|
By Yeongjoo Lee, Joo Hyun O, Seunggyun Ha
| preprints.org
You are already at the latest version Background: This study aimed to evaluate the association between the uptake on F-18 florastamin PET/CT targeting the prostate-specific membrane antigen expression, and the histopathological grade of the primary tumor in newly diagnosed prostate cancer patients.
Open in Who Shared Issue with article?

SPECT/CT Radiomics for Differentiating between Enchondroma and Grade I Chondrosarcoma

|
By Hyukjin Yoon, Woo Hee Choi, Min Wook Joo, Seunggyun Ha
| MDPI
1. Introduction Chondrosarcoma and enchondroma are the most common malignant and benign cartilage-forming bone tumors, respectively. Chondrosarcoma is classified as grade 1–3. Grade 1 chondrosarcomas are now referred to as atypical cartilaginous tumors (ACTs) [1]. While ACTs represent a low-grade tumor, surgical treatment is currently regarded as the only form of curative management. Enchondroma is a benign tumor, and a wait-and-see policy is permissible [2].
Open in Who Shared Issue with article?
See all 9 articles